Curebound Night at the Ballpark is on September 12! Watch the Padres take on the Rockies. $10 of every ticket purchased back to Curebound. Tickets
Skin Cancer
Novel Approaches and New Therapeutic Platforms
Immunotherapies and Personalized Vaccines
Linda Bradley (SBP)
Soo Jin Park (UCSD)
Despite recent advances, malignant melanoma still causes thousands of deaths in the US each year. The goal of this project is to develop a novel, monoclonal antibody-based therapy that can reactivate the tumor-killing properties of the patient’s own immune system. This therapy has the potential to eradicate tumors that are refractory to existing therapy and thus save lives.